RenovoRx (RNXT) Total Liabilities (2020 - 2026)

RenovoRx has disclosed Total Liabilities across 7 years of filings, most recently posting $2.5 million for Q2 2026.

• In Q2 2026, Total Liabilities fell 16.96% year-over-year to $2.5 million; the TTM figure through Jun 2026 stood at $2.5 million (down 16.96% YoY), while the FY2025 annual figure was $2.7 million, down 26.57% from the prior year.
• Total Liabilities came in at $2.5 million for Q2 2026 at RenovoRx, down from $2.7 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $5.1 million in Q2 2023 to a low of $1.1 million in Q3 2022.
• Average Total Liabilities over 5 years is $2.7 million, with a median of $2.8 million recorded in 2024.
• Year-over-year, Total Liabilities sank 93.42% in 2022 and jumped 356.46% in 2023.
• Over 5 years, Total Liabilities stood at $1.1 million in 2022, then soared by 305.26% to $4.5 million in 2023, then fell by 18.5% to $3.6 million in 2024, then declined by 26.57% to $2.7 million in 2025, then dropped by 6.73% to $2.5 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $2.5 million in Q2 2026, $2.7 million in Q1 2026, and $2.7 million in Q4 2025.